BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its holdings in shares of MetLife, Inc. (NYSE:MET – Free Report) by 79.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,726,209 shares of the financial services provider’s stock after buying an additional 762,291 shares during the quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. owned 0.25% of MetLife worth $142,378,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds also recently added to or reduced their stakes in the business. MeadowBrook Investment Advisors LLC increased its holdings in shares of MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. lifted its position in MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 186 shares during the period. Wolff Wiese Magana LLC grew its stake in MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 277 shares during the last quarter. Peterson Financial Group Inc. acquired a new position in shares of MetLife in the third quarter valued at about $30,000. Finally, Fortitude Family Office LLC lifted its holdings in shares of MetLife by 177.3% during the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after purchasing an additional 266 shares during the period. 89.81% of the stock is owned by institutional investors and hedge funds.
MetLife Trading Down 0.0 %
Shares of MET stock opened at $82.60 on Thursday. MetLife, Inc. has a fifty-two week low of $62.14 and a fifty-two week high of $86.94. The firm has a market capitalization of $57.19 billion, a P/E ratio of 16.65, a PEG ratio of 0.75 and a beta of 1.05. The stock’s fifty day moving average is $82.08 and its two-hundred day moving average is $75.84. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16.
MetLife Dividend Announcement
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on the stock. TD Cowen assumed coverage on shares of MetLife in a research report on Wednesday, October 9th. They set a “buy” rating and a $97.00 price target for the company. StockNews.com upgraded shares of MetLife from a “hold” rating to a “buy” rating in a research report on Tuesday, November 12th. Barclays reduced their price target on MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a research report on Thursday, October 31st. Piper Sandler raised their price objective on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd. Finally, Morgan Stanley decreased their target price on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a research note on Monday, August 19th. Fourteen investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $88.46.
Get Our Latest Research Report on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Profitably Trade Stocks at 52-Week Highs
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Which Wall Street Analysts are the Most Accurate?
- Williams-Sonoma Stock: Buy It and Never Let It Go
- How to Invest in Biotech Stocks
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.